Table 5.
Characteristics of the presumed six mother to child HBV transmission (MTCT) cases.
| Infant Characteristics at 12 Months | |||||
|---|---|---|---|---|---|
| Case Number | Gender | Administered Vaccine | HBsAg | Anti-HBs Titer mIU/mL | Anti-HBc |
| 1 | Male | Engerix-B | Positive | 249.8 | Positive |
| 2 | Male | Engerix-B | Positive | 5.68 | Positive |
| 3 | Male | Engerix-B | Positive | 3.16 | Positive |
| 4 | Female | Engerix-B | Positive | 0.85 | Positive |
| 5 | Female | Engerix-B | Positive | 0.2 | Positive |
| 6 | Female | Sci-B-Vac | Positive | 0.4 | Positive |
| Maternal Characteristics | |||||
| Case number | Age at delivery (Years) | Antiviral therapy | HBeAg | Anti-HBe | HBV DNA Log at Delivery |
| 1 | 23 | No | Negative | Positive | <1.28 |
| 2 | 25 | No | Positive | Negative | 5.5 |
| 3 | 32 | No | Positive | Negative | 8.49 |
| 4 | 21 | No | Negative | Positive | 9.53 |
| 5 | 19 | No | Negative | Positive | <1.28 |
| 6 | 26 | No | Positive | Negative | 9.00 |